Faculty Summaries
Tahseen I Al-Saleem, MD
Tahseen I Al-Saleem, MD


  • Al-Saleem T, Zardawi IM. Primary lymphomas of the small intestine in Iraq: a pathological study of 145 cases. Histopathology. 1979;3:89-106.
  • Al-Attar A, Pritchard J, Al-Naimi M, Al-Saleem T, Alash N, Atra A. Intensive chemotherapy for non-localized Burkitt's Lymphoma. Arch Dis Child. 1986;62:1013-9.
  • Young NA, Al-Saleem T, Al-Saleem Z, Ehya H, Smith MR. The value of transformed lymphocyte count in subclassification of non-Hodgkin's lymphoma by fine needle aspiration. Am J Clin Pathol. 1997;108:143-51.
  • Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998;83:2208-16.
  • Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP. Mutational analysis of the von Hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients. Mod Pathol. 2002;15:205-10.
  • Wu H, Smith M, Millenson MM, Nicolaou N, Van Deerlin VM, Addya K, Lessin S, Al-Saleem T. Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. J. Invest. Dermatol. 2003;121:1522-30.
  • Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res. 200363:8695-9.
  • Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG. The genetics of renal oncocytosis; a possible model of neoplastic progression. Cancer Genet. Cytogenet. 2004;152:23-8.
  • Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Promoter hypermethylation profile of kidney cancer. Clin Cancer Res. 2004;10:3972-9.
  • Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (PSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274-80.
  • Al-Saleem T, Balsara BR, Liu Z, Feder M, Testa JR, Wu H, Greenberg RE. Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression? Cancer Genet Cytogenet. 2005;163:81-5.
  • Gitelson E, Al-Saleem T, Millenson M, Lessin S, Smith MR. Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature. Leuk Lymphoma. 2006;47:1902-7.
  • Narra K, Borghaei H, Al-Saleem T, Höglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leuk Res. 2006;30:109-14.
  • D'Ambrosio DJ, Hanlon AL, Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67:1082-7.
  • Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 2008;68:998-1002. Accepted prior to April 7, 2008.
  • Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic concordance of sporadic synchronous bilateral renal masses. Urology. 2008;72:138-42.
  • Jambusaria A, Shafer D, Wu H, Al-Saleem T, Perlis C. Cutaneous plasmablastic lymphoma. J Am Acad Dermatol. 2008;58:676-8. Accepted prior to April 7, 2008.
  • Shafer D, Wu H, Al-Saleem T, Reddy K, Borghaei H, Lessin S, Smith M. Cutaneous precursor B-Cell lymphoblastic lymphoma in2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature. Arch Dermatol. 2008;144:1155-62. Accepted prior to April 7, 2008.
  • Gitelson E, Al-Saleem T, Smith MR. Lymphomatoid granulomatosis; challenges in diagnosis and treatment. Clin Adv Hematol Oncol. 2009;7:68-70.
  • Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A. MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer; RTOG 92-02. J Clin Oncol. 2009;27:3177-84. PMC Journal – In Process
  • Kadariya Y, Yin B, Tang B, Shinton SA, Quinlivan EP, Hua X, Klein-Szanto A, Al-Saleem TI, Bassing CH, Hardy RR, Kruger WD. Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. Cancer Res. 2009;69:5961-9.
  • Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM. The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92002. Clin. Cancer Res. 2009;15:5478-4.
  • Reyes, V.E., Jr., Al-Saleem, T., Robu, V.G., Smith, M.R. Extranodal NK/T-cell lymphoma nasal type: Efficacy of pegaspargase. Report of two patients from United States and review of literature. Leuk Res. 2010;34:e50-54.